We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Court OKs Patent Claim Changes for Novo Nordisk’s Prandin
Court OKs Patent Claim Changes for Novo Nordisk’s Prandin
April 23, 2010
A federal appellate court has ruled that Novo Nordisk does not have to undo changes to the patent claims on its diabetes drug Prandin, even though the company changed those claims after becoming involved in litigation with other drugmakers seeking to make a generic version of the drug.